ATE184200T1 - Verwendung von enzymen insbesondere brorelain zur behandlung von nicht-infektiöser diarrhöe - Google Patents

Verwendung von enzymen insbesondere brorelain zur behandlung von nicht-infektiöser diarrhöe

Info

Publication number
ATE184200T1
ATE184200T1 AT93914851T AT93914851T ATE184200T1 AT E184200 T1 ATE184200 T1 AT E184200T1 AT 93914851 T AT93914851 T AT 93914851T AT 93914851 T AT93914851 T AT 93914851T AT E184200 T1 ATE184200 T1 AT E184200T1
Authority
AT
Austria
Prior art keywords
pct
treatment
brorelain
infectious diarrhea
enzymes especially
Prior art date
Application number
AT93914851T
Other languages
English (en)
Inventor
Tracey Leahanne Mynott
Original Assignee
Cortecs Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929213862A external-priority patent/GB9213862D0/en
Priority claimed from GB939308164A external-priority patent/GB9308164D0/en
Priority claimed from GB939313189A external-priority patent/GB9313189D0/en
Application filed by Cortecs Uk Ltd filed Critical Cortecs Uk Ltd
Application granted granted Critical
Publication of ATE184200T1 publication Critical patent/ATE184200T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT93914851T 1992-06-30 1993-06-30 Verwendung von enzymen insbesondere brorelain zur behandlung von nicht-infektiöser diarrhöe ATE184200T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB929213862A GB9213862D0 (en) 1992-06-30 1992-06-30 Medical use of enzymes
GB939308164A GB9308164D0 (en) 1993-04-20 1993-04-20 Medical use of enzymes
GB939313189A GB9313189D0 (en) 1993-06-25 1993-06-25 Medical use of enzymes

Publications (1)

Publication Number Publication Date
ATE184200T1 true ATE184200T1 (de) 1999-09-15

Family

ID=27266268

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93914851T ATE184200T1 (de) 1992-06-30 1993-06-30 Verwendung von enzymen insbesondere brorelain zur behandlung von nicht-infektiöser diarrhöe

Country Status (13)

Country Link
US (1) US5928640A (de)
EP (1) EP0671943B1 (de)
JP (1) JPH08503691A (de)
AT (1) ATE184200T1 (de)
AU (1) AU672986B2 (de)
CA (1) CA2137674A1 (de)
DE (1) DE69326351T2 (de)
DK (1) DK0671943T3 (de)
ES (1) ES2138625T3 (de)
GR (1) GR3031961T3 (de)
NZ (1) NZ253748A (de)
SG (1) SG42846A1 (de)
WO (1) WO1994000147A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9313188D0 (en) * 1993-06-25 1993-08-11 Cortecs Ltd Medical use of enzymes
US20020102253A1 (en) 1997-02-25 2002-08-01 Mynott Tracey Lehanne Component of bromelain
CN1252101A (zh) * 1997-02-25 2000-05-03 科特克斯(英国)有限公司 菠萝蛋白酶成分
ATE533842T1 (de) * 1997-02-25 2011-12-15 Sarantis Pty Ltd Bromelainbestandteil
DK1096951T3 (da) * 1998-07-15 2002-10-21 Ursapharm Arzneimittel Gmbh Anvendelse af bromelainproteaser til inhiberingen af blodkoaguleringen
US20010046493A1 (en) * 2000-02-24 2001-11-29 Alex Margolin Lipase-containing composition and methods of use thereof
WO2002086136A1 (en) * 2001-04-25 2002-10-31 N.V. Nutricia Process for the manufacture of a fermented health-promoting product
ES2352086T3 (es) * 2004-10-14 2011-02-15 Cystic Fibrosis Foundation Therapeutics, Inc. Composiciones que contienen lipasa, proteasa y amilasa para el tratamiento de la insuficiencia pancreática.
IL165334A0 (en) * 2004-11-22 2006-01-15 Mediwound Ltd Debriding composition from bromelain and methods of producing same
US12556387B2 (en) 2005-01-27 2026-02-17 The Chamberlain Group Llc Method and apparatus to facilitate transmission of an encrypted rolling code
US8422667B2 (en) 2005-01-27 2013-04-16 The Chamberlain Group, Inc. Method and apparatus to facilitate transmission of an encrypted rolling code
US9148409B2 (en) 2005-06-30 2015-09-29 The Chamberlain Group, Inc. Method and apparatus to facilitate message transmission and reception using different transmission characteristics
US20100196344A1 (en) * 2005-10-14 2010-08-05 Cystic Fibrosis Foundation Therapeutics, Inc. Compositions and methods for treating pancreatic insufficiency
EP3337499A4 (de) * 2015-08-20 2019-02-20 Anatara Lifesciences Limited Enzymatische fraktionen mit entzündungshemmender wirkung
EP3408387B1 (de) 2016-01-31 2022-01-05 Mediwound Ltd Debriding-zusammensetzung zur behandlung von wunden
US10652743B2 (en) 2017-12-21 2020-05-12 The Chamberlain Group, Inc. Security system for a moveable barrier operator
US11074773B1 (en) 2018-06-27 2021-07-27 The Chamberlain Group, Inc. Network-based control of movable barrier operators for autonomous vehicles
US11423717B2 (en) 2018-08-01 2022-08-23 The Chamberlain Group Llc Movable barrier operator and transmitter pairing over a network
US10997810B2 (en) 2019-05-16 2021-05-04 The Chamberlain Group, Inc. In-vehicle transmitter training

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617417A1 (de) * 1966-12-08 1971-03-25 Ciba Geigy Pharmazeutisches Praeparat
JPS5299207A (en) * 1976-02-16 1977-08-19 Kaken Pharmaceut Co Ltd Remedy for cattle diarrhea
FR2414554A1 (fr) * 1978-01-13 1979-08-10 Steeg Lottie Nouveau milieu de culture bacterienne et ses applications comme additif alimentaire et medicament pour animaux
JP2798248B2 (ja) * 1986-08-28 1998-09-17 コーテックス リミテッド 生物学的活性物質の動物の腸管部位へのデリバリーに有効なマイクロ顆粒状製剤
AU604052B2 (en) * 1986-08-28 1990-12-06 Enzacor Properties Limited Animal growth promotant
EP0596962A4 (en) * 1991-07-24 1997-01-15 Enzacor Pty Ltd Therapeutic compositions and methods.
US5260074A (en) * 1992-06-22 1993-11-09 Digestive Care Inc. Compositions of digestive enzymes and salts of bile acids and process for preparation thereof
US5302400A (en) * 1992-06-22 1994-04-12 Digestive Care Inc. Preparation of gastric acid-resistant microspheres containing digestive enzymes and buffered-bile acids

Also Published As

Publication number Publication date
SG42846A1 (en) 1997-10-17
DK0671943T3 (da) 2000-03-27
EP0671943A1 (de) 1995-09-20
WO1994000147A1 (en) 1994-01-06
JPH08503691A (ja) 1996-04-23
AU672986B2 (en) 1996-10-24
CA2137674A1 (en) 1994-01-06
HK1004193A1 (en) 1998-11-20
GR3031961T3 (en) 2000-03-31
AU4507493A (en) 1994-01-24
ES2138625T3 (es) 2000-01-16
DE69326351D1 (de) 1999-10-14
EP0671943B1 (de) 1999-09-08
DE69326351T2 (de) 2000-05-18
NZ253748A (en) 1997-06-24
US5928640A (en) 1999-07-27

Similar Documents

Publication Publication Date Title
ATE184200T1 (de) Verwendung von enzymen insbesondere brorelain zur behandlung von nicht-infektiöser diarrhöe
RU94031102A (ru) Сульфамиды в качестве антагонистов эндотелина и способ лечения соответствующих заболеваний
ES2102813T3 (es) Composiciones farmaceuticas y dermocosmeticas que contienen calostro equino.
ATE169445T1 (de) Verwendung von gelformulierungen als beizmittel
DE59509646D1 (de) Mikroorganismen enthaltende granulate
IL116385A0 (en) Sulphonamides their manufacture and pharmaceutical compositions containing them
DE69508192D1 (de) Wasserlösliches nimesulid-salz, sowie dessen verwendung zur behandlung von entzündungen
ATE202701T1 (de) Behandlung und prophylaxe von durch parasiten oder bakterien verursachten erkrankungen
KR960701051A (ko) 이미다조피리딘 및 이를 위장 질환의 치료에 사용하는 방법(imidazopyridines and their use in treating castrointestinal diseases)
CA2165824A1 (fr) Utilisation du modafinil pour la fabrication d'un medicament ayant un effet sur les apnees du sommeil et les troubles ventilatoires d'origine centrale
DK0755249T3 (da) Anvendelse af Maillard-reaktionsinhibitor til behandling af amyloidose-baseret sygdom
FI946185A0 (fi) Ligniinin polymerointi alkalisessa pH:ssa
EP0595995A4 (en) Arylamidoalkyl-n-hydroxyurea compounds having lipoxygenase inhibitory activity
FI970203A0 (fi) Pyridyylitioyhdisteet helikobakteerien torjumiseksi
ATE226058T1 (de) Verwendung von lysin zur behandlung des haarausfalls
FI961054A0 (fi) Menetelmä 9-(2-hydroksi)etoksimetyyliguaniinin valmistamiseksi
ATE193206T1 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
DK164176C (da) Bacillus subtilis dsm 2704 og anvendelse heraf i en fremgangsmaade til fremstilling af alfa-amylase
DE69400702D1 (de) N-acylpyrrolidine und arzneimittel zur behandlung oder prophylaxe von mit ckk und gastrin in zusammenhang stehenden krankheiten
DE69427116D1 (de) Verwendung von 4'-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis
GB9304399D0 (en) Novel process
DK1033993T3 (da) Anvendelse af Escherichia coli stamme DSM 6601 i veterinærsektoren til behandling af diarré
ATE165509T1 (de) Avermectine und milbemycine zur behandlung von parazitären infektionen beim hund
DK0703916T3 (da) 14-Substituerede marcfortiner og derivater, der kan anvendes som antispirant-midler
CZ145095A3 (en) Novel triazoloquinazolines, process of their preparation and use

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee